Cleared Special

K262240 - SSPC NXT Delivery Catheter

K262240 is an FDA 510(k) clearance for SSPC NXT Delivery Catheter, manufactured by CenterPoint Systems, LLC. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 28-day FDA review.

K262240 · CenterPoint Systems, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2026
Decision
28d
Days
Class 2
Risk

K262240 is an FDA 510(k) clearance for the SSPC NXT Delivery Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by CenterPoint Systems, LLC (West Valley City, US). The FDA issued a Cleared decision on July 29, 2026 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all CenterPoint Systems, LLC devices

FDA 510(k) Submission Details - K262240

510(k) Number K262240 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2026
Decision Date July 29, 2026
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K262240.
NHanceIT
K260559 · IMDS Operation B.V. · Aug 2026
APRO 35 Swift Catheter
K262392 · Alembic, LLC · Aug 2026
CPS Locator 3D Plus Delivery Catheter
K261766 · CenterPoint Systems, LLC · Jul 2026
Amplatzer TorqVue LP Delivery System
K261825 · Abbott · Jul 2026
Amplatzer TorqVue Exchange System
K261631 · Abbott Medical · Jun 2026
Perfect-O Ostial Positioning Catheter
K260289 · Balosmark, Inc. · Jun 2026